See All Slides - tctmd.com

Slides

Presentation TCT 2013

TCT-74. Carotid Lesion Length Effect on Routine Doppler Velocities Used to Determine Carotid Stenosis Cross-Sectional Severity: Intravascular Ultrasound-Validated Analysis in th...

Presenter: Wladyslaw Dabrowski

October 29, 2013

Presentation TCT 2013

Allogeneic Cardiac-Derived Cells for STEMI

Presenter: Raj Makkar

October 29, 2013

Presentation TCT 2013

TCT-41. One-year Results From the MASTER Trial, a Prospective, Randomized, Multicenter Evaluation of an Embolic Protection Stent (MGuard) in Patients with STEMI Undergoing Prima...

Presenter: Dariusz Dudek

October 29, 2013

Presentation TCT 2013

Selective Use of Intravascular Imaging and Physiologic Lesion Assessment to Improve Patient Outcomes

Presenter: Gary Mintz

October 29, 2013

Presentation TCT 2013

Appropriateness Use Criteria Recommendations for SIHD: Strengths, Limitations, and Evolution of Terminology and Process

Presenter: Manesh Patel

October 29, 2013

Presentation TCT 2013

The Role of Chordal Preserving MVR for Degenerative Disease and How to Do It!

Presenter: Francis Wells

October 29, 2013

Presentation TCT 2013

TCT-15. Results of the Primary Endpoint of the PLATINUM PLUS Trial: A Prospective, Randomized, Multi-center Trial to Assess the Everolimus-Eluting Coronary Stent System (PROMUS...

Presenter: Jean Fajadet

October 29, 2013

Presentation

Next-Day Discharge: The Vancouver Experience

Presenter: David Wood

October 29, 2013

Presentation TCT 2013

TCT-27. The Impact of Second Generation Drug-eluting Stent on Mid-term Clinical Outcome in Patients with Unprotected Left Main, Milan and New-Tokyo Registry

Presenter: Kensuke Takagi

October 29, 2013

Presentation TCT 2013

Aspirin Dead, Warfarin Still Alive

Presenter: Kristen Patton

October 29, 2013

Advertisement

Slides

TCT-74. Carotid Lesion Length Effect on Routine Doppler Velocities Used to Determine Carotid Stenosis Cross-Sectional Severity: Intravascular Ultrasound-Validated Analysis in th...

Allogeneic Cardiac-Derived Cells for STEMI

TCT-41. One-year Results From the MASTER Trial, a Prospective, Randomized, Multicenter Evaluation of an Embolic Protection Stent (MGuard) in Patients with STEMI Undergoing Prima...

Selective Use of Intravascular Imaging and Physiologic Lesion Assessment to Improve Patient Outcomes

Appropriateness Use Criteria Recommendations for SIHD: Strengths, Limitations, and Evolution of Terminology and Process

The Role of Chordal Preserving MVR for Degenerative Disease and How to Do It!

TCT-15. Results of the Primary Endpoint of the PLATINUM PLUS Trial: A Prospective, Randomized, Multi-center Trial to Assess the Everolimus-Eluting Coronary Stent System (PROMUS...

Next-Day Discharge: The Vancouver Experience

TCT-27. The Impact of Second Generation Drug-eluting Stent on Mid-term Clinical Outcome in Patients with Unprotected Left Main, Milan and New-Tokyo Registry

Aspirin Dead, Warfarin Still Alive

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content